Weight gain after gastric sleeve surgery is a recognised concern that affects a proportion of patients in the years following their procedure. Sleeve gastrectomy — one of the most commonly performed bariatric operations in the UK — delivers significant weight loss initially, but physiological, behavioural, and psychological factors can contribute to gradual weight regain over time. Understanding why this happens, what is considered clinically significant, and what support is available through the NHS is essential for anyone navigating life after bariatric surgery. This article outlines the key causes, warning signs, and evidence-based treatment options to help patients and clinicians manage this complex, chronic condition effectively.

Why Weight Gain Can Occur After Gastric Sleeve Surgery

Weight regain after sleeve gastrectomy occurs because gastric capacity can increase over time, ghrelin suppression may not be permanent, and obesity is a chronic, relapsing condition requiring long-term follow-up.

Have any more questions about this? Message our pharmaceutical team to get more info →

Gastric sleeve surgery, formally known as sleeve gastrectomy, is one of the most commonly performed bariatric procedures in the UK. It involves removing approximately 75–80% of the stomach, creating a narrow, tube-shaped pouch that restricts food intake and reduces hunger. The procedure works through both restriction of stomach capacity and significant hormonal changes, including a reduction in the appetite-regulating hormone ghrelin and favourable shifts in other gut hormones such as GLP-1 and PYY. For most patients, this results in significant and sustained weight loss in the first one to two years following surgery.

However, weight regain after sleeve gastrectomy is a recognised phenomenon that affects a proportion of patients over time. Evidence suggests that many patients reach their lowest weight approximately 12–18 months post-operatively, after which some degree of weight regain may occur; more notable increases are often reported between three and five years after the procedure. This does not mean the surgery has 'failed' — rather, it reflects the complex, multifactorial nature of obesity as a chronic, relapsing condition.

Over time, the capacity of the sleeve may increase due to changes in gastric compliance, allowing larger portion sizes and reducing the sensation of early fullness. Additionally, the initial suppression of ghrelin may not be permanent, and appetite can return as hormonal adaptations occur. Understanding why weight regain happens is the first step towards addressing it effectively and maintaining long-term health outcomes. The NHS and BOMSS (British Obesity and Metabolic Surgery Society) both recognise that long-term follow-up and support are essential components of post-bariatric care.

Common Causes of Weight Regain Following a Sleeve Gastrectomy

Weight regain is typically caused by a combination of increased gastric capacity, hormonal adaptation, metabolic changes, grazing behaviour, emotional eating, and certain medications including corticosteroids and some antidepressants.

Weight regain after a sleeve gastrectomy is rarely attributable to a single cause. It typically results from a combination of physiological, behavioural, and psychological factors that interact over time.

Physiological causes include:

• Increased gastric capacity: The sleeve's capacity may increase over time, allowing greater food volume and reducing the sensation of early fullness.

• Hormonal adaptation: Ghrelin levels, initially suppressed post-surgery, may partially recover, increasing appetite. Changes in other gut hormones (GLP-1, PYY) may also diminish over time.

• Metabolic adaptation: The body's resting metabolic rate can decrease in response to sustained caloric restriction, making further weight loss more difficult.

• Endocrine conditions: Undiagnosed or poorly controlled conditions such as hypothyroidism or Cushing's syndrome can contribute to weight regain and should be considered if weight gain is unexplained or rapid. Life-stage factors such as the perimenopause may also play a role.

Behavioural and psychological causes include:

• Return to high-calorie, low-nutrient food choices, particularly ultra-processed foods and sugary drinks that pass through the sleeve easily.

• Grazing behaviour — eating small amounts continuously throughout the day — which can significantly increase total caloric intake without triggering fullness.

• Emotional or stress-related eating patterns that were not fully addressed prior to surgery.

• Increased alcohol consumption, which contributes both calories and carries additional risks after bariatric surgery, including a heightened risk of alcohol use disorder. NHS guidance advises patients to avoid alcohol after bariatric surgery, particularly in the first year.

Medication-related causes: Certain medicines are associated with weight gain, including corticosteroids, some antidepressants (particularly mirtazapine and tricyclic antidepressants), antipsychotics, insulin, sulfonylureas, pioglitazone, valproate, and some beta-blockers. If you have started a new medicine and noticed changes in your weight, it is important to discuss this with your GP or bariatric team, who may be able to consider weight-neutral or weight-reducing alternatives where clinically appropriate. There is no evidence that any of these medicines directly cause an increase in sleeve capacity. The BNF and NICE provide guidance on medicines associated with weight change.

How Much Weight Regain Is Considered Normal?

Clinicians recommend review when a patient regains more than 10% of their lowest post-operative weight or when obesity-related comorbidities return, rather than applying a single fixed threshold.

Defining 'normal' weight regain after a sleeve gastrectomy requires careful consideration of individual baseline weight, surgical outcomes, and long-term follow-up data. In clinical practice, bariatric teams typically assess outcomes using measures such as excess weight loss (EWL%) — the percentage of excess body weight lost relative to an ideal body weight benchmark — and total weight loss percentage (TWL%), which reflects the proportion of total body weight lost and is increasingly used in UK practice.

Studies suggest that most patients achieve their lowest weight approximately 12–18 months after surgery. Beyond this point, some degree of weight regain is common; published estimates suggest that a regain of around 20–30% of the total weight lost may be seen in a proportion of patients over several years, though there is considerable individual variation and these figures should be interpreted cautiously. For example, if a patient lost 40 kg following surgery, regaining 8–12 kg over several years would fall within this range.

Rather than applying fixed thresholds, clinicians generally recommend earlier review whenever there is a persistent upward trend in weight — for instance, regaining more than 10% of the lowest post-operative weight — or when obesity-related health conditions begin to return or worsen. A return of comorbidities such as worsening blood glucose control, rising blood pressure, or sleep apnoea warrants prompt clinical assessment regardless of the absolute amount of weight regained.

NICE guidance (CG189) and BOMSS follow-up recommendations both emphasise that obesity is a chronic relapsing condition, and weight regain should be approached without stigma — as a medical issue requiring clinical support rather than a personal failing.

Dietary and Lifestyle Factors That Contribute to Weight Gain

Liquid calories, calorie-dense soft foods, reduced protein intake, grazing, and declining physical activity are the key dietary and lifestyle factors that contribute to weight regain after sleeve gastrectomy.

Long-term success after a sleeve gastrectomy is closely tied to sustained dietary and lifestyle changes. Over time, many patients find that the strict post-operative dietary habits they initially followed begin to relax, which can gradually contribute to weight regain.

Key dietary factors to be mindful of include:

• Liquid calories: Sugary drinks, fruit juices, alcohol, and high-calorie smoothies are not restricted by the sleeve and can contribute significantly to caloric surplus.

• Soft, calorie-dense foods: Foods such as crisps, chocolate, ice cream, and pastries are easily consumed in larger quantities as they do not trigger the same fullness response as solid, high-protein meals.

• Reduced protein intake: Protein promotes satiety and preserves lean muscle mass. A decline in protein consumption over time can increase hunger and slow metabolism. Individual protein targets should be discussed with a specialist bariatric dietitian.

• Grazing: Eating continuously in small amounts throughout the day bypasses the restriction mechanism of the sleeve.

• Alcohol: As noted above, alcohol contributes calories and carries specific risks after bariatric surgery. If you are concerned about your alcohol intake, speak to your GP or contact NHS support services.

Lifelong nutritional supplementation and monitoring: BOMSS guidance recommends that all patients who have undergone sleeve gastrectomy take lifelong vitamin and mineral supplements and attend regular blood tests to monitor for nutritional deficiencies, including iron, vitamin B12, vitamin D, folate, and calcium. Patients should ensure they remain engaged with their bariatric team or GP for scheduled biochemical monitoring, even if they feel well.

Lifestyle factors are equally important. Reduced physical activity, poor sleep quality, and chronic stress are all independently associated with weight regain. The UK Chief Medical Officers' guidelines recommend at least 150 minutes of moderate-intensity aerobic activity per week for adults, alongside muscle-strengthening activities on two or more days. Patients who maintain regular exercise following bariatric surgery consistently demonstrate better long-term weight maintenance. Psychological support, including cognitive behavioural therapy (CBT) for disordered eating patterns, can also play a meaningful role in sustaining healthy behaviours.

When to Seek Medical Advice From Your Bariatric Team

Patients should contact their bariatric team or GP if they experience consistent weight regain over several months, returning comorbidities, disproportionate hunger, or emotional difficulties related to eating.

Knowing when to seek professional support is an important aspect of long-term post-operative care. Many patients feel reluctant to contact their bariatric team after weight regain, often due to embarrassment or a belief that they have 'let themselves down.' It is essential to challenge this perception — bariatric teams are specifically trained to support patients through the full spectrum of post-operative experiences, including weight regain.

Contact your bariatric team or GP if you notice:

• Consistent weight regain over several months, particularly if you have regained more than 10% of your lowest post-operative weight.

• A return or worsening of obesity-related health conditions such as blood glucose control, rising blood pressure, or increased joint pain.

• Significant changes in appetite, including persistent hunger that feels disproportionate to your food intake.

• Emotional difficulties, including low mood, anxiety, or disordered eating behaviours, which are common in people who have undergone bariatric surgery. Your GP can refer you to psychological support services.

Seek urgent medical attention (same-day GP, NHS 111, or A&E as appropriate) if you experience:

• Severe or persistent abdominal pain.

• Persistent vomiting or inability to keep fluids down.

• Signs of dehydration (dark urine, dizziness, dry mouth).

• Difficulty swallowing or new, persistent gastro-oesophageal reflux.

• Any rectal bleeding or signs of gastrointestinal bleeding.

These symptoms may indicate a surgical complication and require prompt assessment.

NICE guidance on obesity management (CG189) and NICE Quality Standard QS127 both emphasise the importance of long-term follow-up for patients who have undergone bariatric surgery. BOMSS recommends a minimum of two years of structured specialist follow-up, with ongoing monitoring in primary care thereafter. Patients should be aware that support beyond the initial follow-up period may need to be accessed via GP referral or self-referral to community weight management services.

Treatment and Support Options Available on the NHS

NHS options include specialist dietetic and psychological support, pharmacological therapy such as semaglutide (NICE TA875) within specialist services, and revisional bariatric surgery for carefully selected patients.

For patients experiencing significant weight regain after a sleeve gastrectomy, a range of treatment and support options are available within the NHS, though access may vary by region and local commissioning arrangements.

Dietary and behavioural support remains the cornerstone of management. Referral to a specialist bariatric dietitian can help patients reassess their eating patterns, address nutritional deficiencies, and develop a sustainable dietary plan. Psychological support, including CBT or specialist bariatric psychology services, can address underlying emotional eating and improve long-term adherence to lifestyle changes.

Pharmacological options may be considered in appropriate cases, and prescribing decisions should always be made on an individual basis by a qualified clinician.

• Semaglutide (Wegovy): A GLP-1 receptor agonist that reduces appetite and slows gastric emptying. NICE technology appraisal guidance (TA875) supports its use for weight management in adults with a BMI of 35 kg/m² or above (or 30–34.9 kg/m² with at least one weight-related comorbidity, with ethnicity-adjusted thresholds applying in some groups) alongside a reduced-calorie diet and increased physical activity. Under TA875, semaglutide must be initiated and supervised within specialist weight management services, and treatment is currently approved for a maximum duration of two years. Evidence for its use specifically in post-bariatric populations is still emerging, and its use in this context requires individualised MDT assessment. Please refer to the electronic Medicines Compendium (emc) SmPC for Wegovy for full prescribing information, contraindications, and monitoring requirements. Suspected adverse reactions should be reported via the MHRA Yellow Card Scheme.

• Liraglutide (Saxenda): Also a GLP-1 receptor agonist and MHRA-licensed for weight management in the UK. However, liraglutide does not currently have a NICE technology appraisal supporting routine NHS commissioning for obesity, and availability is subject to local formulary and commissioning decisions. Please refer to the emc SmPC for Saxenda for full prescribing information.

• Orlistat (Xenical): An older weight management medicine that inhibits fat absorption. It may be considered in some patients but should be used with caution after sleeve gastrectomy, as it can exacerbate fat-soluble vitamin deficiencies (vitamins A, D, E, and K). If orlistat is prescribed, close nutritional monitoring and bariatric dietetic input are essential. Please refer to the emc SmPC for Xenical for full prescribing information.

Revisional bariatric surgery — such as conversion from sleeve gastrectomy to Roux-en-Y gastric bypass — may be considered in carefully selected patients where conservative measures have been unsuccessful. This is assessed on a case-by-case basis by a multidisciplinary bariatric team in line with BOMSS guidance. Availability within the NHS is limited and varies by region.

Patients should discuss all available options openly with their clinical team, approaching weight regain as a manageable medical condition rather than an insurmountable setback. Regional variation in access to specialist services means that GP referral may be required to access some of these options.

Frequently Asked Questions